The Nifty Midcap 100 Index achieved a new milestone on Tuesday, closing at 64,450.90 points, representing a 0.5% gain from the previous session. According to latest reports, the index was driven by strong performances from key stocks including Steel Authority of India, Glenmark Pharma, LIC Housing Finance, and Laurus Labs. However, this midcap strength comes against a backdrop of broader market challenges, with the Sensex currently experiencing its worst two-year return stretch since 2012. As per The Economic Times, the Sensex has gone 697 days without a new record high, marking its longest stretch of weakness in years. In 2026, 37% of trading days have delivered negative two-year returns, the highest share since 2012, while 62.3% of trading days this year have ended with negative one-year returns.
Despite the strong performance, the Nifty Midcap 100 now trades at a price-to-earnings (P/E) multiple of 33.8x, which analysts consider expensive territory. As reported by Business Standard, this valuation level is well below the index's unprecedented high of 44x in September 2024, but remains a concern for market participants. The midcap segment has demonstrated superior earnings growth, with the index's earnings per share (EPS) rising 23% over the past year, compared to the Nifty 50's 11% EPS growth. This growth differential has been supported by improving earnings growth reflected in Q1 2026-27 numbers and better-than-expected guidance from companies.
The broader markets outperformed benchmark indices during the week, with both Nifty Midcap and Smallcap indices gaining 0.5% each. The Nifty Smallcap 100 index touched a record high of 20,143.55, supported by double-digit gains in Capri Global Capital, IDBI Bank, IFCI, and Ather Energy. Sectoral performance was mixed, with Nifty Metal, IT, Pharma, and Healthcare indices rising more than 2% each, while Nifty FMCG, Infrastructure, and Oil & Gas indices declined 1% each. Nifty Capital Markets gained 1.5%, and Nifty Auto and Defence indices slipped nearly 1% each. According to Kotak Securities, the benchmark indices witnessed range-bound activity after a roller coaster ride, with Nifty 50 falling 0.31% to 24,175.65 and Sensex declining 0.35% to 77,264.51.
Foreign institutional investors remained net sellers for the second consecutive week, offloading equities worth ₹20,260 crore during the week, while domestic institutional investors provided support by investing ₹19,309.93 crore in equities. The total market capitalisation of BSE-listed companies declined by a little over ₹1 lakh crore during the week. According to HSBC, India may be one portfolio rebalance away from attracting about $25 billion in foreign equity inflows, as global fund managers seek shelter from volatility in AI-heavy Asian markets. More than 80% of active global emerging-market funds are underweight India, and if those funds simply restore their allocations to neutral, the shift could generate around $25 billion of inflows.
Market experts remain cautious about the sustainability of current valuations amid broader market weakness. According to Kotak Securities, the short-term market texture is weak, with a fresh selloff possible only if the 24,100/77,100 level is broken, potentially leading to a decline to 24,000-23,800/76,800-76,200. However, if the index manages to trade above the 50-day SMA at 24,200/77,500, it could retest the 20-day SMA at 24,350/77,900 and potentially lift the index to 24,500/78,400. SBI Securities expects the 24,000-23,970 zone to act as crucial support for the index, with a decisive breach below 23,970 triggering further weakness toward 23,820. On the upside, the 24,300-24,330 zone is likely to act as immediate resistance, with a sustained move above this zone required to improve near-term outlook.
